about
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.The establishment and utility of Sweha-Reg: a Swedish population-based registry to understand hereditary angioedemaHLA-Cw*0602 associates with a twofold higher prevalence of positive streptococcal throat swab at the onset of psoriasis: a case control studyGrenz ray treatment of lentigo maligna and early lentigo maligna melanoma.Employment is maintained and sick days decreased in psoriasis/psoriatic arthritis patients with etanercept treatment.Association of Psoriatic Disease With Uveitis: A Danish Nationwide Cohort Study.Metabolic disorders in patients with psoriasis and psoriatic arthritis.Psoriasis and Sleep Apnea: A Danish Nationwide Cohort StudyPsoriasis beyond the skin: a review of the literature on cardiometabolic and psychological co-morbidities of psoriasis.The relationship between duration of psoriasis, vascular inflammation, and cardiovascular events.Herpes zoster in psoriasis patients treated with tofacitinib.Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study.Psoriasis: The Poster Child for Bench-to-bedside Translational Medicine.Etanercept reduces symptoms and severity of psoriasis after cessation of cyclosporine therapy: results of the SCORE study.Molecular Insights into Fully Human and Humanized Monoclonal Antibodies: What are the Differences and Should Dermatologists Care?Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials.Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study.Economic Burden of Psoriasis and Potential Cost Offsets with Biologic Treatment: A Swedish Register Analysis.Increased risk of migraine in patients with psoriasis: A Danish nationwide cohort study.Ten-year mortality is increased after hospitalization for atopic dermatitis compared with the general population, but reduced compared with psoriasis.STG does not associate with psoriasis in the Swedish population.Family history predicts major adverse cardiovascular events (MACE) in young adults with psoriasis.Swedish children with hereditary angioedema report good overall health and quality of life despite symptoms.Risk of Multiple Sclerosis in Patients with Psoriasis: A Danish Nationwide Cohort Study.Hereditary Angioedema in Swedish Adults: Report From the National Cohort.Increased cause-specific mortality in patients with mild and severe psoriasis: a population-based Swedish register study.Impact of Depression on Risk of Myocardial Infarction, Stroke and Cardiovascular Death in Patients with Psoriasis: A Danish Nationwide Study.Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin.Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis.Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients.Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.A higher score on the dermatology life quality index, being on systemic treatment and having a diagnosis of psoriatic arthritis is associated with increased costs in patients with plaque psoriasis.Injury downregulates the expression of the human cathelicidin protein hCAP18/LL-37 in atopic dermatitis.Distinct HLA-C/KIR genotype profile associates with guttate psoriasis.
P50
Q29417009-C54DEDF8-9215-49C4-8518-E7BA4AC03B14Q33308287-3157E614-458D-49CD-B08E-B2FC7A075D84Q33456175-100BBBD0-961C-4650-BF3A-80246B875B71Q34059246-7CB63856-5020-459D-B4D8-FCCA8FE7A724Q34103030-913EEF93-8AD2-4981-8420-DCEC3D2DEF54Q34671931-9A8CBD55-B010-4C82-8864-A15337E3B66DQ36594227-2ED35AFD-53BE-4AD9-A4E7-45515081A1D1Q36897052-F5125910-87A0-4F22-AB05-E698EE2FE871Q38206102-056F7E09-2C29-4FC7-A96F-2546BC770E61Q38615718-0330512E-FC1C-4F79-92AE-333794667AF5Q38677741-A176ABA5-9890-4C75-9183-E9678FD063B0Q38797089-234C8210-949C-4E61-A1A1-A3E4BFECADF3Q38981907-7E685108-7737-4F3F-A3B8-785597D0A741Q39209268-2CF341AD-8043-4EBC-B4B8-417588CC7D7BQ39347886-A2DE9069-DD38-4C37-9488-905EDB261681Q39684745-2693FA04-A4AA-4820-9204-953E05390FA4Q39775030-E7683F96-32CB-454A-9821-ABCFC8C3C7C4Q39980767-114FA47B-0161-45EF-916C-E2B9C6F7051AQ40159569-CEA3CEDC-72BD-498F-A614-0550E078D624Q40522377-F0600F32-BB79-4B75-B4A6-B610EC08F1D5Q40541726-47D919B5-59BF-4173-92A2-7A965A771A00Q40541792-63461561-28FC-4BAF-A34C-480E5C53E4CAQ40709127-9BFC9C08-E5D9-4CEA-99B6-B4A31C7706B9Q40944856-4EAD6C0E-50AA-4F36-A1DA-58F5529FBDB1Q40979771-1F4DCFC6-1B0A-4893-B7DA-7D910BF26F88Q41147654-DDB25570-D70A-4D38-B474-8E4F28159525Q41232222-59658776-D20E-44A8-8E3D-7B6831BFB994Q41477188-DE82BB29-DC90-4359-B06D-61CC21550180Q42528570-2F2A5548-A51B-433F-862F-F2A707A6A034Q43280124-EFC67A89-6B7B-447A-98FA-51F0D11EFD8EQ43813250-3154A096-4722-4608-AA46-2015E53A26CDQ44374991-73AD831B-BB12-4A00-9569-CDFA4EED5BCAQ44662060-640985D7-4C24-4106-B648-7296EA4D922FQ45914882-399F1B70-AE46-4A67-BFFC-730AB7E57385Q46721466-A965A954-DA6C-4754-B6D8-6A119E12C78F
P50
name
Lotus Mallbris
@ast
Lotus Mallbris
@en
Lotus Mallbris
@es
Lotus Mallbris
@nl
type
label
Lotus Mallbris
@ast
Lotus Mallbris
@en
Lotus Mallbris
@es
Lotus Mallbris
@nl
prefLabel
Lotus Mallbris
@ast
Lotus Mallbris
@en
Lotus Mallbris
@es
Lotus Mallbris
@nl